Literature DB >> 20965575

Localized retinal neuropeptide regulation of macrophage and microglial cell functionality.

Norikuni Kawanaka1, Andrew W Taylor.   

Abstract

The functionality of immune cells is manipulated within the ocular microenvironment to protect the sensitive and non-regenerating light-gathering tissue from the collateral damage of inflammation. This is mediated partly by the constitutive presence of immunomodulating neuropeptides. Treating primary resting macrophages with soluble factors produced by the posterior eye induced co-expression of Arginase1 and NOS2. The neuropeptides alpha-melanocyte stimulating hormone and Neuropeptide Y alternatively activated the macrophages to co-express Arginase1 and NOS2 like myeloid suppressor cells. Similar co-expressing cells were found within healthy, but not in wounded retinas. Therefore, the healthy retina regulates macrophage functionality to the benefit of ocular immune privilege.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20965575      PMCID: PMC3030990          DOI: 10.1016/j.jneuroim.2010.09.025

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  46 in total

1.  Changes with aging in the modulation by neuropeptide Y of murine peritoneal macrophage functions.

Authors:  M De la Fuente; M Del Río; S Medina
Journal:  J Neuroimmunol       Date:  2001-06-01       Impact factor: 3.478

2.  The anti-inflammatory effect of neuropeptide Y (NPY) in rats is dependent on dipeptidyl peptidase 4 (DP4) activity and age.

Authors:  Mirjana Dimitrijević; Stanislava Stanojević; Katarina Mitić; Natasa Kustrimović; Vesna Vujić; Tatjana Miletić; Vesna Kovacević-Jovanović
Journal:  Peptides       Date:  2008-09-03       Impact factor: 3.750

Review 3.  The eye's view of antigen presentation.

Authors:  J Wayne Streilein; Sharmila Masli; Masaru Takeuchi; Takeshi Kezuka
Journal:  Hum Immunol       Date:  2002-06       Impact factor: 2.850

4.  Differential turnover rates of monocyte-derived cells in varied ocular tissue microenvironments.

Authors:  Jelena Kezic; Paul G McMenamin
Journal:  J Leukoc Biol       Date:  2008-06-24       Impact factor: 4.962

5.  Injection of an alpha-melanocyte stimulating hormone expression plasmid is effective in suppressing experimental autoimmune uveitis.

Authors:  D J Lee; D J Biros; A W Taylor
Journal:  Int Immunopharmacol       Date:  2009-05-06       Impact factor: 4.932

6.  Characteristics of bone marrow-derived microglia in the normal and injured retina.

Authors:  Hiroki Kaneko; Koji M Nishiguchi; Makoto Nakamura; Shu Kachi; Hiroko Terasaki
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-16       Impact factor: 4.799

7.  Ocular immune privilege.

Authors:  A W Taylor
Journal:  Eye (Lond)       Date:  2009-01-09       Impact factor: 3.775

8.  Neuropeptide Y promotes TGF-beta1 production in RAW264.7 cells by activating PI3K pathway via Y1 receptor.

Authors:  Jiang-Rui Zhou; Zheng Xu; Chun-Lei Jiang
Journal:  Neurosci Bull       Date:  2008-06       Impact factor: 5.203

Review 9.  Exploring the full spectrum of macrophage activation.

Authors:  David M Mosser; Justin P Edwards
Journal:  Nat Rev Immunol       Date:  2008-12       Impact factor: 53.106

Review 10.  Myeloid-derived suppressor cells as regulators of the immune system.

Authors:  Dmitry I Gabrilovich; Srinivas Nagaraj
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

View more
  21 in total

1.  Tissue-specific production of MicroRNA-155 inhibits melanocortin 5 receptor-dependent suppressor macrophages to promote experimental autoimmune uveitis.

Authors:  Fauziyya Muhammad; Anna Trivett; Dawei Wang; Darren J Lee
Journal:  Eur J Immunol       Date:  2019-06-19       Impact factor: 5.532

Review 2.  Negative regulators that mediate ocular immune privilege.

Authors:  Andrew W Taylor; Tat Fong Ng
Journal:  J Leukoc Biol       Date:  2018-02-12       Impact factor: 4.962

3.  Neuropeptide Y levels are associated with nutritional status and cardiovascular events in adults with chronic kidney disease.

Authors:  L Lu; Y-C Zou; M Wang; Y-F Huang; D-X Chen; L-B Wei
Journal:  Eur J Clin Nutr       Date:  2015-04-29       Impact factor: 4.016

4.  Melanocortin receptor agonists suppress experimental autoimmune uveitis.

Authors:  Tat Fong Ng; Kaleb Dawit; Andrew W Taylor
Journal:  Exp Eye Res       Date:  2022-02-20       Impact factor: 3.770

5.  Both MC5r and A2Ar are required for protective regulatory immunity in the spleen of post-experimental autoimmune uveitis in mice.

Authors:  Darren J Lee; Andrew W Taylor
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

6.  The neuropeptides α-MSH and NPY modulate phagocytosis and phagolysosome activation in RAW 264.7 cells.

Authors:  Toan A Phan; Andrew W Taylor
Journal:  J Neuroimmunol       Date:  2013-05-17       Impact factor: 3.478

Review 7.  Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms.

Authors:  Tamás Rőszer
Journal:  Mediators Inflamm       Date:  2015-05-18       Impact factor: 4.711

8.  Alpha-melanocyte stimulating hormone (α-MSH) is a post-caspase suppressor of apoptosis in RAW 264.7 macrophages.

Authors:  Andrew W Taylor
Journal:  PLoS One       Date:  2013-08-29       Impact factor: 3.240

9.  Extracellular Soluble Membranes from Retinal Pigment Epithelial Cells Mediate Apoptosis in Macrophages.

Authors:  Nayan Sanjiv; Pawarissara Osathanugrah; Emma Fraser; Tat Fong Ng; Andrew W Taylor
Journal:  Cells       Date:  2021-05-13       Impact factor: 6.600

10.  Early retinal inflammatory biomarkers in the middle cerebral artery occlusion model of ischemic stroke.

Authors:  Rodney M Ritzel; Sarah J Pan; Rajkumar Verma; John Wizeman; Joshua Crapser; Anita R Patel; Richard Lieberman; Royce Mohan; Louise D McCullough
Journal:  Mol Vis       Date:  2016-06-04       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.